In neurodegenerative diseases, while other insulin sensitizers like pioglitazone improve insulin sensitivity, metformin’s broader impact on oxidative stress, mitochondrial dysfunction, and protein aggregation, through AMPK activation and mTOR inhibition, offers a more comprehensive neuroprotective strategy [12,304]. This evidence concerns the gene INS and neurodegenerative disease.